Full-Time

Director – Project Management

Posted on 8/26/2024

Cytokinetics

Cytokinetics

501-1,000 employees

Develops drugs for muscle function disorders

Biotechnology
Healthcare

Compensation Overview

$216k - $264kAnnually

Senior

San Bruno, CA, USA

Category
Project Management
Business & Strategy
Required Skills
PowerPoint/Keynote/Slides
Requirements
  • Bachelor's degree in a related field (Project Management, Business Administration, etc.) with 12+ years of experience in project management, specifically within the pharmaceutical industry
  • Proven expertise in project management methodologies, tools, and best practices, including MS Project, OnePager, Smartsheet, and PowerPoint
  • Demonstrated experience leading project management teams and study operating teams for Phase 2/3/4 clinical trials in late-stage development
  • Strong ability to influence and persuade stakeholders, driving consensus and facilitating decision-making processes in a collaborative manner
  • Exceptional communication, interpersonal, and leadership skills, essential for effectively communicating project objectives, strategies, and progress to stakeholders across all levels of the organization
  • PMP certification or equivalent is a plus
Responsibilities
  • Collaborate with Clinical Study Operating Team to monitor project progress, identify risks, and develop effective mitigation strategies to keep clinical trial on track
  • Facilitate and lead effective Product Strategy Team meetings, including the creation of effective meeting agendas and clear documentation of key issues for discussion, decisions made and assigned action items
  • Partner with Clinical Research and Commercial Product Strategy Team leaders to develop recommendations for risk mitigation, prioritization at quarterly Portfolio Review Committee meetings
  • Maintain project management processes, procedures, and best practices to streamline trial execution and ensure consistency across the entire R&D pipeline
  • Collaborate cross-functionally to support corporate initiatives, defining scopes, objectives, and deliverables in alignment with organizational goals
  • Develop and maintain comprehensive project plans, timelines, and budgets using tools such as excel, MS Project, OnePager, PowerBI, and Smartsheet

Cytokinetics focuses on developing medicines that improve muscle function for patients with cardiovascular and neuromuscular diseases. Their products are small molecule drugs designed to either enhance or inhibit muscle function, tailored to specific therapeutic needs. The company has a range of drugs in clinical trials, including omecamtiv mecarbil and reldesemtiv, aimed at treating conditions like heart failure, hypertrophic cardiomyopathy, amyotrophic lateral sclerosis, and spinal muscular atrophy. Unlike many competitors, Cytokinetics emphasizes rigorous scientific research and has conducted over 50 clinical trials to ensure the effectiveness of its treatments. The goal is to bring new therapies to market that address the unmet needs of patients suffering from debilitating muscle-related conditions.

Company Stage

IPO

Total Funding

$58.4M

Headquarters

South San Francisco, California

Founded

1998

Growth & Insights
Headcount

6 month growth

2%

1 year growth

1%

2 year growth

14%
Simplify Jobs

Simplify's Take

What believers are saying

  • Cytokinetics secured $575M funding from Royalty Pharma for aficamten's commercial launch.
  • Positive Phase III trial results for aficamten show significant improvements in HCM treatment.
  • Public offering priced at $51/share expected to raise $500M, indicating strong market confidence.

What critics are saying

  • Competition from Bristol-Myers Squibb's Camzyos could impact aficamten's market share.
  • Reliance on successful clinical trials poses financial risks if outcomes are negative.
  • Financial strategy depends on external funding, risking instability if partnerships fail.

What makes Cytokinetics unique

  • Cytokinetics focuses on muscle activators and inhibitors for cardiovascular and neuromuscular diseases.
  • The company has a robust pipeline including omecamtiv mecarbil and aficamten.
  • Cytokinetics educates healthcare professionals on hypertrophic cardiomyopathy through 'HCM Beyond the Heart' campaign.

Help us improve and share your feedback! Did you find this helpful?

INACTIVE